These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 12229247)

  • 1. [A rare case of cholestasis and macrohematuria in a 52-year-old patient].
    Arkenau HT; Widjaja A
    Med Klin (Munich); 2002 Aug; 97(8):480-3. PubMed ID: 12229247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe intrahepatic cholestasis and rapidly progressive renal failure in a patient with immunocyte-related amyloidosis.
    Skander MP; Harry DS; Lee FI
    J Clin Gastroenterol; 1987 Apr; 9(2):219-22. PubMed ID: 3106463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [An unusual cause of hepatorenal symptoms].
    Frank H; Krammer M; Fierlbeck W; Riess R; Geiger H
    Med Klin (Munich); 1999 May; 94(5):274-8. PubMed ID: 10408189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myeloma and severe cholestasis.
    Licht A; Maurer R; Oelz O
    Schweiz Med Wochenschr; 1999 Aug; 129(34):1201-4. PubMed ID: 10486860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. κ I light chain AL amyloidosis presenting with rapidly progressive renal and hepatic failure with unusual renal amyloid distribution.
    Oe Y; Nakaya I; Yahata M; Murata O; Yaegashi H; Sakuma T; Sato H; Liepnieks JJ; Benson MD; Soma J
    Clin Nephrol; 2012 Jan; 77(1):66-70. PubMed ID: 22185971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasotropic light-chain amyloidosis and ischaemic cholangiopathy.
    Johnston EL; Wilkinson M; Knisely AS
    BMJ Case Rep; 2015 Jun; 2015():. PubMed ID: 26113598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obstructive jaundice caused by the deposition of amyloid-like substances in the extrahepatic and large intrahepatic bile ducts in a patient with multiple myeloma.
    Terada T; Hirata K; Hisada Y; Hoshii Y; Nakanuma Y
    Histopathology; 1994 May; 24(5):485-7. PubMed ID: 8088723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatomegaly and cholestasis as primary clinical manifestations of an AL-kappa amyloidosis.
    Mohr A; Miehlke S; Klauck S; Röcken C; Malfertheiner P
    Eur J Gastroenterol Hepatol; 1999 Aug; 11(8):921-5. PubMed ID: 10514129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of prominent hepatic cholestasis developing to hepatic failure in lambda-AL amyloidosis.
    Dohmen K; Nagano M; Iwakiri R; Yamano Y; Kikuchi Y; Mizoguchi M; Iwata Y; Mori Y; Ishibashi H
    Gastroenterol Jpn; 1991 Jun; 26(3):376-81. PubMed ID: 1889693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Severe recurrent intrahepatic cholestasis in systemic AL amyloidosis without obvious liver involvement: unexplained hepatic toxicity or a case of misdiagnosed liver amyloidosis?].
    Paudice N; Farsetti S; Caroti L; Bandini S; Ciuti G; Tempestini A; Perfetto F; Galli S; Giabbani L; Caldini AL; Bergesio F
    G Ital Nefrol; 2012; 29(1):92-7. PubMed ID: 22388910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary amyloidosis presenting as intrahepatic cholestasis.
    Bandyopadhyay SK; Bandyopadhyay R; Dutta A
    Indian J Pathol Microbiol; 2006 Oct; 49(4):557-9. PubMed ID: 17183853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Asymptomatic immunoglobulin light chain amyloidosis (AL) at the time of diagnostic bone marrow biopsy in newly diagnosed patients with multiple myeloma and smoldering myeloma. A series of 144 cases and a review of the literature.
    Siragusa S; Morice W; Gertz MA; Kyle RA; Greipp PR; Lust JA; Witzig TE; Lacy MQ; Zeldenrust SR; Rajkumar SV; Russell SJ; Hayman SR; Buadi F; Kumar SK; Dingli D; Dispenzieri A
    Ann Hematol; 2011 Jan; 90(1):101-6. PubMed ID: 20645101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholestasis and renal failure in a patient with secondary amyloidosis.
    Unsal C; Paydaş S; Gönlüşen G
    Ren Fail; 2002 Nov; 24(6):863-6. PubMed ID: 12472208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Congo red-positive cardiac kappa-AL amyloidosis in plasmacytoma -- case report and review of the literature.
    Tzankov A; Pölzl G; Mairinger T
    Acta Med Austriaca; 2003; 30(1):29-32. PubMed ID: 12558564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Two autopsy cases with systemic amyloidosis--case 11/2010].
    Schott S; Artunc F; Haap M; Mackensen-Haen S; Fend F; Riessen R
    Dtsch Med Wochenschr; 2010 Nov; 135(44):2186. PubMed ID: 20979003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic failure in a case of multiple myeloma-associated amyloidosis (kappa-AL).
    Yamamoto T; Maeda N; Kawasaki H
    J Gastroenterol; 1995 Jun; 30(3):393-7. PubMed ID: 7647907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Light chain deposition disease of the liver associated with AL-type amyloidosis and severe cholestasis.
    Faa G; Van Eyken P; De Vos R; Fevery J; Van Damme B; De Groote J; Desmet VJ
    J Hepatol; 1991 Jan; 12(1):75-82. PubMed ID: 1901075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sarcoid, amyloid and heart failure.
    Rakhit RD; Clesham GJ; Cleland JG
    Int J Cardiol; 1993 Sep; 41(2):180-2. PubMed ID: 8282446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic amyloidosis presenting with severe intrahepatic cholestasis.
    Goenka MK; Bhasin DK; Vasisth RK; Dhawan S
    J Clin Gastroenterol; 1996 Sep; 23(2):134-6. PubMed ID: 8877643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Massive systemic amyloidosis associated with light-chain deposition disease.
    Troussard X; Hurault de Ligny B; Gallet B; Ganeval D; Mandard JC; Ryckelynck JP; Leporrier M
    Nephron; 1989; 52(2):139-43. PubMed ID: 2500613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.